Publications

Student Publications

  1. CM Sielaff, SA Mousa (2018) Status and future directions in the management of pancreatic cancer: Potential impact of nanotechnology Journal of Cancer Research and Clinical Oncology 144:1205-1217.
  2. AA Abd-Rabou, DJ Bharali, SA Mousa (2018) Taribavirin and 5-fluorouracil-loaded pegylated-lipid nanoparticle synthesis, p38 docking, and antiproliferative effects on MCF-7 breast cancer Pharmaceutical Research 35:76.
  3. MH Elberry, NHE Darwish, SA Mousa (2017) Hepatitis C virus management: Potential impact of nanotechnology Virology Journal 14:88.
  4. P Gladfelter, NHE Darwish, SA Mousa (2017) Current status and future direction in the management of malignant melanoma Melanoma Research 27:403-410.
  5. JW Potts, SA Mousa (2017) Recent advances in management of autosomal-dominant polycystic kidney disease American Journal of  Health System Pharmacy 74:1959-1968.
  6. ZT Sahli, J Jo, SA Mousa, FI Tarazi (2017) Clinical management of restless legs syndrome in end-stage renal disease patients CNS Spectrums 22:14-21.
  7. LA Della Badia, NA Elshourbagy, SA Mousa (2016) Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol Pharmacology & Therapeutics 164:183-194.
  8. SM Brady, L Shapiro, SA Mousa (2016) Current and future direction in the management of scleroderma Archives of Dermatological Research 308:461-471.
  9. BR Yasin, HA El-Fawal, SA Mousa (2015) Date (Phoenix dactylifera) polyphenolics and other bioactive compounds: A traditional islamic remedy’s potential in prevention of cell damage, cancer therapeutics and beyond International Journal of Molecular Sciences 16:30075-30090.
  10. F Tarazi, Z Sahil, J Pleskow, SA Mousa (2015) Asperger’s Syndrome: diagnosis, comorbidity and therapy Expert Review of Neurotherapeutics 15:281-293.
  11. V Belousova, AA Abd-Rabou, SA Mousa (2015) Recent Advances and Future Directions in the Management of Hepatitis C Infections Pharmacology & Therapeutics 145C:92-102.
  12. R Vogel, EA Hussein, SA Mousa (2015) Stem Cells in the Management of Heart Failure: What Have We Learned from Clinical Trials? Expert Review of Cardiovascular Therapy 13:75-83.
More
  1. DS Bombard, 2nd, SA Mousa (2014) Mayer-Rokitansky-Kuster-Hauser Syndrome: Complications, Diagnosis and Possible Treatment Options: A Review Gynecological Endocrinology 30:618-623.
  2. J Ebright, SA Mousa (2014) Oral Anticoagulants and Status of Antidotes for the Reversal of Bleeding Risk Clinical and Applied Thrombosis/Hemostasis 21:105-114.
  3. FI Tarazi, ZT Sahli, M Wolny, SA Mousa (2014) Emerging Therapies for Parkinson’s Disease: From Bench to Bedside Pharmacology & Therapeutics 144:123-133.
  4. T Sweezy, SA Mousa (2014) Genotype-Guided Use of Oral Antithrombotic Therapy: A Pharmacoeconomic Perspective Personalized Medicine 11:223-235.
  5. M Thomas, SS Mousa, SA Mousa (2013) Comparative Effectiveness of Aflibercept for the Treatment of Patients with Neovascular Age-Related Macular Degeneration Clinical Ophthalmology 7:495-501.
  6. NE Larche, SA Mousa (2013) Riociguat for the Management of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Drugs of Today (Barc) 49:761-768.
  7. T Khushnud, SA Mousa (2013) Potential Role of Naturally Derived Polyphenols and Their Nanotechnology Delivery in Cancer Molecular Biotechnology 55:78-86.
  8. AY Kardys, DJ Bharali, SA Mousa (2013) Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer Journal of Nanotechnology DOI 10.1155/2013/768724.
  9. J Jalaly, J Dalfino, SA Mousa (2013) Onyx(R) in the Management of Cranial Arteriovenous Malformations Expert Review of Medical Devices 10:453-459.
  10. SS Azad, ER Isenovic, S Yaturu, SA Mousa (2013) Insulin Therapy for Diabetes In: Masuo K (ed) Type 2 Diabetes. InTech.
  11. CW Yang, SA Mousa (2012) The Effect of Red Yeast Rice (Monascus Purpureus) in Dyslipidemia and Other Disorders Complementary Therapies in Medicine 20:466-474.
  12. D Swanson, R Block, SA Mousa (2012) Omega-3 Fatty Acids EPA and DHA: Health Benefits Throughout Life Advances in Nutrition 3:1-7.
  13. J Stanekzai, ER Isenovic, SA Mousa (2012) Treatment Options for Diabetes: Potential Role of Stem Cells Diabetes Research and Clinical Practice 98:361-368.
  14. NJ Rogers, SA Mousa (2012) The Shortcomings of Clinical Trials Assessing the Efficacy of Probiotics in Irritable Bowel Syndrome Journal of Alternative and Complementary Medicine 18:112-119.
  15. H Patel, M Qari, SA Mousa (2012) Iron Balance in Β-Thalassemia: Maintaining an Antioxidant / Oxidant Ratio Journal of Applied Hematology 3:4-11.
  16. S Pabani, SA Mousa (2012) Current and Future Treatment of Pulmonary Hypertension Drugs of Today 48:133-147.
  17. JC Keimer, SA Mousa (2012) Expanding the Role of Community Pharmacy: An Evaluation of Generic Drug Discount Programs, Pharmacy Based Immunization Services and Convenient Care Clinics International Journal of Pharmacy 2:1-7.
  18. G Beidoe, SA Mousa (2012) Current Primary Open-Angle Glaucoma Treatments and Future Directions Clinical Ophthalmology 6:1699-1707.
  19. W Aman, S Mousa, G Shiha, SA Mousa (2012) Current Status and Future Directions in the Management of Chronic Hepatitis C Virology Journal 9:57.
  20. J Ramli, P CalderonArtero, RC Block, SA Mousa (2011) Novel Therapeutic Targets for Preserving a Healthy Endothelium: Strategies for Reducing the Risk of Vascular and Cardiovascular Disease Cardiology Journal 18:352-363.
  21. D Laurenzo, SA Mousa (2011) Mechanisms of Drug Resistance in Mycobacterium Tuberculosis and Current Status of Rapid Molecular Diagnostic Testing Acta Tropica 119:5-10.
  22. S Clayton, SA Mousa (2011) Therapeutics Formulated to Target Cancer Stem Cells: Is It in Our Future? Cancer Cell International 11:7.
  23. J-Y Byun, SA Mousa (2011) Thromboprophylaxis in Cancer Patients Receiving Bevacizumab Journal of Applied Hematology 2:273-279.

PRI Staff Publications

  1. E Shinderman-Maman, C Weingarten, D Moskovich, H Werner, A Hercbergs, PJ Davis, M Ellis, O Ashur-Fabian (2018) Molecular insights into the transcriptional regulatory role of thyroid hormones in ovarian cancer Molecular Carcinogenesis 57:97-105.
  2. BM Ayoub, S Mowaka, MM Safar, N Ashoush, MG Arafa, HE Michel, MM Tadros, MM Elmazar, SA Mousa (2018) Repositioning of omarigliptin as a once-weekly intranasal anti-parkinsonian agent Science Reports 8:8959.
  3. AA Abd-Rabou, DJ Bharali, SA Mousa (2018) Taribavirin and 5-fluorouracil-loaded pegylated-lipid nanoparticle synthesis, p38 docking, and antiproliferative effects on MCF-7 breast cancer Pharmaceutical Research 35:76.
  4. PJ Davis, JL Leonard, HY Lin, M Leinung, SA Mousa (2018) Molecular basis of nongenomic actions of thyroid hormone In:  G. Litwack (Ed.) Vitamins and Hormones, Academic Press, Chapter 4, pages 67-96.
  5. A Hercbergs, SA Mousa, PJ Davis (2018) Nonthyroidal illness syndrome and thyroid hormone actions at integrin αvβ3 The Journal of Clinical Endocrinology & Metabolism 103:1291-1295.
  6. A Hercbergs, SA Mousa, M Leinung, HY Lin, PJ Davis (2018) Thyroid hormone in the clinic and breast cancer Hormones and Cancer 9:139-143.
  7. AW Nana, YT Chin, CY Lin, Y Ho, JA Bennett, YJ Shih, YR Chen, CA Changou, JZ Pedersen, S Incerpi, LF Liu, J Whang-Peng, E Fu, WS Li, SA Mousa, HY Lin, PJ Davis (2018) Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer Endocrine-Related Cancer 25:279-293.
  8. MJ Martinez-Zapata, AG Mathioudakis, SA Mousa, R Bauersachs (2018) Tinzaparin for long-term treatment of venous thromboembolism in patients with cancer: A systematic review and meta-analysis Clinical and Applied Thrombosis-Hemostasis 24:226-234.
  9. DJ Bharali, T Sudha, H Cui, BM Mian, SA Mousa (2017) Anti-CD24 nano-targeted delivery of docetaxel for the treatment of prostate cancer Nanomedicine 13:263-273.
  10. L Fu, K Li, D Mori, M Hirakane, L Lin, N Grover, P Datta, Y Yu, J Zhao, F Zhang, M Yalcin, SA Mousa, JS Dordick, RJ Linhardt (2017) Enzymatic generation of highly anticoagulant bovine intestinal heparin Journal of Medicinal Chemistry 60:8673-8679.
  11. MT Hsieh, LM Wang, CA Changou, YT Chin, YSH Yang, HY Lai, SY Lee, YN Yang, J Whang-Peng, LF Liu, HY Lin, SA Mousa, PJ Davis (2017) Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells Oncotarget 8:24237-24249.
  12. JT Leith, PJ Davis, SA Mousa, AA Hercbergs (2017) In vitro effects of tetraiodothyroacetic acid combined with X-irradiation on basal cell carcinoma cells Cell Cycle 16:367-373.
  13. W Li, M Yalcin, Q Lin, MM Ardawi, SA Mousa (2017) Self-assembly of green tea catechin derivatives in nanoparticles for oral lycopene delivery J Control Release, 248:117-124.
  14. V Muralidharan-Chari, J Kim, SA Mousa (2017) Reversal of anticoagulant activity of heparin and low molecular weight heparins by poly-L-lysine: A comparative ‘in vitro’ study versus protamine sulfate Thrombosis Research 155:128-130.
  15. S Nallanthighal, C Chan, DJ Bharali, SA Mousa, E Vasquez, R Reliene (2017) Particle coatings but not silver ions mediate genotoxicity of ingested silver nanoparticles in a mouse model NanoImpact 5:92-100.
  16. M Rajabi, SA Mousa (2017) The role of angiogenesis in cancer treatment Biomedicines 5:34.
  17. M Srinivasan, DJ Bharali, T Sudha, M Khedr, I Guest, S Sell, GV Glinsky, SA Mousa (2017) Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation Oncotarget 8:38731-38742.
  18. T Sudha, DJ Bharali, S Sell, NHE Darwish, PJ Davis, SA Mousa (2017) Nanoparticulate tetrac inhibits growth and vascularity of glioblastoma xenografts Hormones and Cancer 8:157-165.
  19. T Sudha, DJ Bharali, M Yalcin, NH Darwish, MD Coskun, KA Keating, HY Lin, PJ Davis, SA Mousa (2017) Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac Nanomedicine (London) 12:195-205.
  20. T Sudha, DJ Bharali, M Yalcin, NH Darwish, M Debreli Coskun, KA Keating, HY Lin, PJ Davis, SA Mousa (2017) Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac International Journal of Nanomedicine 12:1305-1315.
  21. A Abou-ElNaga, G Mutawa, IM El-Sherbiny, H Abd-ElGhaffar, AA Allam, J Ajarem, SA Mousa (2017) Novel nano-therapeutic approach actively targets human ovarian cancer stem cells after xenograft into nude mice  International Journal of Molecular Science 18:813.
  22. BM Ayoub, S Mowaka, ES Elzanfaly, N Ashoush, MM Elmazar, SA Mousa (2017) Pharmacokinetic evaluation of empagliflozin in healthy Egyptian volunteers using LC-MS/MS and comparison with other ethnic populations Science Reports 7:2583.
  23. MS Atta, EA Almadaly, AH El-Far, RM Saleh, DH Assar, SK Al Jaouni, SA Mousa (2017) Thymoquinone defeats diabetes-induced testicular damage in rats targeting antioxidant, inflammatory and aromatase expression International Journal of Molecular Sciences 18(5).
  24. Y-T Chin, L-M Wang, M-T Hsieh, Y-J Shih, AW Nana, CA Changou, Y-CSH Yang, H-C Chiu, E Fu, PJ Davis, H-Y Tang, H-Y Lin (2017) Leptin OB3 peptide suppresses leptin-induced signaling and progression in ovarian cancer cells Journal of Biomedical Science 24:51.
  25. Y Ho, YS Lin, HL Liu, YJ Shih, SY Lin, A Shih, YT Chin, YR Chen, HY Lin, PJ Davis (2017) Biological mechanisms by which antiproliferative actions of resveratrol are minimized Nutrients 9(10).
  26. MA Abdel-Latif, AH El-Far, AR Elbestawy, R Ghanem, SA Mousa, HS Abd El-Hamid (2017) Exogenous dietary lysozyme improves the growth performance and gut microbiota in broiler chickens targeting the antioxidant and non-specific immunity mRNA expression PLoS One 12:e0185153.
  27. E Block, B Bechand, S Gundala, A Vattekkatte, K Wang, SS Mousa, K Godugu, M Yalcin, SA Mousa (2017) Fluorinated analogs of organosulfur compounds from garlic (allium sativum): Synthesis, chemistry and anti-angiogenesis and antithrombotic studies Molecules 22:2081.
  28. RC Block, A Holub, A Abdolahi, XM Tu, SA Mousa, MN Oda (2017) Effects of aspirin in combination with EPA and DHA on HDL-C cholesterol and ApoA1 exchange in individuals with type 2 diabetes mellitus Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) 126:25-31.
  29. NHE Darwish, T Sudha, K Godugu, O Elbaz, HA Abdelghaffar, EEA Hassan, SA Mousa (2016) Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: Potential impact of BMI-1, TIM-3 and CLL-1 Oncotarget 7:57811-57820.
  30. PJ Davis, GV Glinsky, HY Lin, SA Mousa (2016) Actions of thyroid hormone analogues on chemokines Journal of Immunology Research 2016:3147671.
  31. A Hercbergs, PJ Davis, HY Lin, SA Mousa (2016) Possible contributions of thyroid hormone replacement to specific behaviors of cancer Biomedicine & Pharmacotherapy 84:655-659.
  32. HY Lin, YT Chin, AW Nana, YJ Shih, HY Lai, HY Tang, M Leinung, SA Mousa, PJ Davis (2016) Actions of L-thyroxine and nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells Steroids 114:59-67.
  33. V Muralidharan-Chari, J Kim, A Abuawad, M Naeem, HD Cui, SA Mousa (2016) Thymoquinone modulates blood coagulation in vitro via its effects on inflammatory and coagulation pathways International Journal of Molecular Sciences 17:474.
  34. V Muralidharan-Chari, HG Kohan, AG Asimakopoulos, T Sudha, S Sell, K Kannan, M Boroujerdi, PJ Davis, SA Mousa (2016) Microvesicle removal of anticancer drugs contributes to drug resistance in human pancreatic cancer cells Oncotarget 7:50365-50379.
  35. V Muralidharan-Chari, SA Mousa (2016) Ciraparantag. Heparin neutralizer anticoagulant reversal agent Drugs of the Future 41:341-346.
  36. M Rajabi, SA Mousa (2016) Lipid nanoparticles and their application in nanomedicine Current Pharmaceutical Biotechnology 17:662-672.
  37. M Rajabi, T Sudha, NHE Darwish, PJ Davis, SA Mousa (2016) Synthesis of MR-49, a deiodinated analog of tetraiodothyroacetic acid (tetrac), as a novel pro-angiogenesis modulator Bioorganic & Medicinal Chemistry Letters 26:4112-4116.
  38. YC Yang, YT Chin, MT Hsieh, HY Lai, CC Ke, DR Crawford, OK Lee, E Fu, SA Mousa, P Grasso, LF Liu, HY Chang, HY Tang, HY Lin, PJ Davis (2016) Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin Oncotarget 7:27641-27654.
  39. PJ Davis, T Sudha, HY Lin, SA Mousa (2015) Thyroid hormone, hormone analogs, and angiogenesis Comprehensive Physiology 6:353-362.
  40. HY Lin, GV Glinsky, SA Mousa, PJ Davis (2015) Thyroid hormone and anti-apoptosis in tumor cells Oncotarget 6:14735-14743.
  41. M Rajabi, Z Hossaini, MA Khalilzadeh, S Datta, M Halder, SA Mousa (2015) Synthesis of a new class of furo [3,2-c] coumarins and its anticancer activity Journal of Photochemistry and Photobiology B: Biology 148:66-72.
  42. AM Safer, NA Hanafy, DJ Bharali, HD Cui, SA Mousa (2015) Effect of green tea extract encapsulated into chitosan nanoparticles on hepatic fibrosis collagen fibers assessed by atomic force microscopy in rat hepatic fibrosis model Journal of Nanoscience and Nanotechnology 15:6452-6459.
  43. W Hariri*, T Sudha*, DJ Bharali, H Cui, SA Mousa (2015) Nano-Targeted Delivery of Toremifene, an Estrogen Receptor-α Blocker in Prostate Cancer Pharmaceutical Research 32:2764-2774. *Contributed equally
  44. A Bani-Jaber, H Cui, A Elsaid, M Yalcin, T Sudha, SA Mousa (2015) Pegylated Solid Lipid Nanoparticles Reconstituted From High-Density Lipoprotein components for Hepatic Targeting Science Letters Journal 4:145.
  45. PJ Davis, GV Glinsky, HY Lin, JT Leith, A Hercbergs, HY Tang, O Ashur-Fabian, S Incerpi, SA Mousa (2015) Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac Frontiers in Endocrinology 5:240.
  46. A Alshaiban, V Muralidharan-Chari, A Nepo, SA Mousa (2015) Modulation of Sickle Red Blood Cell Adhesion and Its Associated Changes in Biomarkers by Sulfated Nonanticoagulant Heparin Derivative Clinical and Applied Thrombosis/Hemostasis 22:230-238.
  47. R Alyahya, T Sudha, M Racz, SC Stain, SA Mousa (2015) Anti-Metastasis Efficacy and Safety of Non-Anticoagulant Heparin Derivative Versus Low Molecular Weight Heparin in Surgical Pancreatic Cancer Models Int J Oncol 46:1225-1231
  48. AB Shirode, DJ Bharali, S Nallanthighal, JK Coon, SA Mousa, R Reliene (2015) Nanoencapsulation of Pomegranate Bioactive Compounds for Breast Cancer Chemoprevention International Journal of Nanomedicine 10:475-484.
  49. PJ Davis, HY Lin, T Sudha, M Yalcin, HY Tang, A Hercbergs, JT Leith, MK Luidens, O Ashur-Fabian, S Incerpi, SA Mousa (2014) Nanotetrac Targets Integrin αvβ3 on Tumor Cells to Disorder Cell Defense Pathways and Block Angiogenesis Onco Targets Ther 7:1619-1624.
  50. IA Siddiqui, DJ Bharali, M Nihal, VM Adhami, N Khan, JC Chamcheu, MI Khan, S Shabana, SA Mousa, H Mukhtar (2014) Excellent Anti-Proliferative and Pro-Apoptotic Effects of (-)-Epigallocatechin-3-Gallate Encapsulated in Chitosan Nanoparticles on Human Melanoma Cell Growth Both in Vitro and in Vivo Nanomedicine 10:1619-1626.
  51. T Sudha, M Yalcin, HY Lin, AM Elmetwally, T Nazeer, T Arumugam, P Phillips, SA Mousa (2014) Suppression of Pancreatic Cancer by Sulfated Non-Anticoagulant Low Molecular Weight Heparin Cancer Letters 350:25-33.
  52. SA Mousa, HY Lin, HY Tang, A Hercbergs, MK Luidens, PJ Davis (2014) Modulation of Angiogenesis by Thyroid Hormone and Hormone Analogues: Implications for Cancer Management Angiogenesis 17:463-469.
  53. N Khan, DJ Bharali, VM Adhami, IA Siddiqui, H Cui, SM Shabana, SA Mousa, H Mukhtar (2014) Oral Administration of Naturally Occurring Chitosan-Based Nanoformulated Green Tea Polyphenol EGCG Effectively Inhibits Prostate Cancer Cell Growth in a Xenograft Model Carcinogenesis 35:415-423.
  54. M Yalcin, HY Lin, T Sudha, DJ Bharali, R Meng, HY Tang, FB Davis, SC Stain, PJ Davis, SA Mousa (2013) Response of Human Pancreatic Cancer Cell Xenografts to Tetraiodothyroacetic Acid Nanoparticles Hormones and Cancer 4:176-185.
  55. A Rebbaa, G Patil, M Yalcin, T Sudha, SA Mousa (2013) OT-404, Multi-Targeted Anti-Cancer Agent Affecting Tumor Proliferation, Chemo-Resistance, and Angiogenesis Cancer Letters 332:55-62.
  56. SA Mousa (2013) Comparative Pharmacodynamic Assessment of the Antiangiogenesis Activity of Heparin and Low-Molecular-Weight Heparin Fractions: Structure-Function Relationship Clinical and Applied Thrombosis/Hemostasis 19:48-54.
  57. AA Lugade, DJ Bharali, V Pradhan, G Elkin, SA Mousa, Y Thanavala (2013) Single Low-Dose Un-Adjuvanted HBsAG Nanoparticle Vaccine Elicits Robust, Durable Immunity Nanomedicine 9:923-934.
  58. HY Lin, YF Su, MT Hsieh, S Lin, R Meng, D London, C Lin, HY Tang, J Hwang, FB Davis, SA Mousa, PJ Davis (2013) Nuclear Monomeric Integrin αv in Cancer Cells Is a Coactivator Regulated by Thyroid Hormone FASEB Journal 27:3209-3216.
  59. PJ Davis, SA Mousa, V Cody, HY Tang, HY Lin (2013) Small Molecule Hormone or Hormone-Like Ligands of Integrin αVβ3: Implications for Cancer Cell Behavior Hormes and Cancer 4:335-342.
  60. PJ Davis, HY Lin, HY Tang, FB Davis, SA Mousa (2013) Adjunctive Input to the Nuclear Thyroid Hormone Receptor from the Cell Surface Receptor for the Hormone Thyroid 23:1503-1509.
  61. PJ Davis, GV Glinsky, HY Lin, S Incerpi, FB Davis, SA Mousa, HY Tang, A Hercbergs, MK Luidens (2013) Molecular Mechanisms of Actions of Formulations of the Thyroid Hormone Analogue, Tetrac, on the Inflammatory Response Endocrine Research 38:112-118.
  62. DJ Bharali, M Yalcin, PJ Davis, SA Mousa (2013) Tetraiodothyroacetic Acid-Conjugated Plga Nanoparticles: A Nanomedicine Approach to Treat Drug-Resistant Breast Cancer  Nanomedicine (London) 8:1943-1954.
  63. DJ Bharali, SA Mousa (2013) Relevance of Nanotechnology in Modulating Oxidative Stress: An Overview Methods in Molecular Biology 1028:289-292
  64. DJ Bharali, D Armstrong, SA Mousa (2013) Hybrid Polymeric Nanoparticles: Potential Candidate for Ophthalmic Delivery Methods in Molecular Biology 1028:279-286.
  65. T Sudha, P Phillips, C Kanaan, RJ Linhardt, L Borsig, SA Mousa (2012) Inhibitory Effect of Non-Anticoagulant Heparin (S-Nach) on Pancreatic Cancer Cell Adhesion and Metastasis in Human Umbilical Cord Vessel Segment and in Mouse Model Clin Exp Metastasis 29:431-439
  66. MH Qari, U Dier, SA Mousa (2012) Biomarkers of Inflammation, Growth Factor, and Coagulation Activation in Patients with Sickle Cell Disease Clinical and Applied Thrombosis/Hemostasis 18:195-200
  67. SA Mousa, M Yalcin, DJ Bharali, R Meng, HY Tang, HY Lin, FB Davis, PJ Davis (2012) Tetraiodothyroacetic Acid and Its Nanoformulation Inhibit Thyroid Hormone Stimulation of Non-Small Cell Lung Cancer Cells in Vitro and Its Growth in Xenografts Lung Cancer 76:39-45
  68. SA Mousa (2012) The Future of Anticoagulant Therapy Cardiovascular Therapeutics 30:255-256.
  69. HY Lin, HY Tang, FB Davis, SA Mousa, S Incerpi, MK Luidens, R Meng, PJ Davis (2012) Nongenomic Regulation by Thyroid Hormone of Plasma Membrane Ion and Small Molecule Pumps  Discovery Medicine 14:199-206.
  70. MS Jayaraman, DJ Bharali, T Sudha, SA Mousa (2012) Nano Chitosan Peptide as a Potential Therapeutic Carrier for Retinal Delivery to Treat Age-Related Macular Degeneration Molecular Vision 18:2300-2308.
  71. A Aljada, SA Mousa (2012) Metformin and Neoplasia: Implications and Indications Pharmacology & Therapeutics 133:108-115.